End of Standard registration: September 30, 2019
Abstract submission deadline: July 27, 2019
PLEASE READ THIS THOROUGHLY BEFORE PREPARING YOUR ABSTRACT
1.Only abstracts written in English will be accepted.
2.The abstract should contain no more than 300 words.
3.CAPITALIZE the entire title and UNDERLINE the name of author who will present the paper. Abbreviations must not be used in the title. After the title, list the author’s names and institutional affiliations; please OMIT degrees, titles, institutional appointments, address and zip code. The text should be typed using single spacing. Do not indent the title and each paragraph.
4.Abbreviations must be defined by placing them in parentheses after the full word the first time they appear. Use numerals to indicate numbers except when beginning sentences.
5.Nonproprietary (generic) names, written in lower-case letters, are required the first time a drug is mentioned. Proprietary names are always capitalized.
6.Abstract will appear exactly as submitted. Abstract with smudges, errors, misspellings, incorrect hyphenations, faint typing, etc. (or not conforming to the prescribed rules) will require retyping at the author’s expense
7.PLEASE CHECK ONE KEY WORD in the abstract submission form, which best categorizes the subject of the abstract.
8.The abstract will be published in the congress book after the registration is complete.
9.Deadline for submission is July 27,2019
10.Please submit your abstract via the system and specify the type of abstract (oral/poster presentation) desired.